EU-RESOLVE Weekly Webinar Series
The EU-RESOLVE Weekly Webinar Series was launched during the first year of the EU-RESOLVE COST Action, with its first webinar taking place on 19 November 2025. Since then, the series has grown into a regular forum for scientific exchange within the EU-RESOLVE community.
By the end of September 2026, the series had hosted 31 webinars, featuring one or two presenters in each session and attracting a strong and engaged audience from across the EU-RESOLVE network.
The weekly online webinars provide a valuable space for knowledge sharing, scientific discussion, and collaboration, giving members of the Action the opportunity to present their research, share ongoing work and recent findings, and discuss emerging topics in Resolution Biology with colleagues from different backgrounds and institutions. The interactive format also encourages questions, exchange of ideas, and the development of new scientific connections across the network.
Through this ongoing series, EU-RESOLVE aims to foster a dynamic and collaborative scientific community, promoting the exchange of expertise and strengthening connections between researchers working in the field of Resolution Biology.
Below, you can explore the webinars held during the first year of the EU-RESOLVE Weekly Webinar Series, including information about the presenters and the topics discussed.
First year weekly webinars (1-31):
| Webinar | Date | Speakers (affiliation): Title |
|---|---|---|
| 2025 | ||
| 1 | 19th November | Mauro Perretti (Queen Mary University of London, United Kingdom): Our approach to research and ongoing projects – Resolution Biology and Pharmacology Marcela Hortová Kohoutková and Jan Frič (ICRC, Czech Republic): Sepsis and Resolution of Inflammation |
| 2 | 26th November | Robert Klaus Hofstetter and Oliver Werz (Friedrich-Schiller Universität Jena, Germany): Reporting of Specialized Pro-Resolving Mediators: An update on current best practices Denise Biagini (Università di Pisa, Italy): Development and validation of LC- & GC-MS based methods for Health and Disease assessment |
| 3 | 3rd December | Michael J. Davies (University of Copenhagen, Denmark): Analysis of protein changes in inflammation and cardiovascular disease Eoin Brennan (University College Dublin, Ireland): Lipoxin A4 mimetics targeting vascular complications of diabetes |
| 4 | 10th December | Juan Bautista De Sanctis (Palacky University, Czech Republic): Lipoproteins, fatty acids, resolvins and immune response Jianmin Chen (Queen Mary University of London, United Kingdom): Fpr2-Driven Resolution as Therapeutic Targets for Arthritis-Associated Cardiomyopathy |
| 5 | 17th December | Matti Van Welzen and Shailendra Gupta (University of Rostock, Germany): Specialized proresolving interactome, a knowledge graph to explore mechanism of SPM function |
| 2026 | ||
| 6 | 7th January | Saara Laitinen (Finnish Red Cross Blood Service, Finland): Extracellular vesicles from cells and blood: signalling machinery of membrane Magdalena Flak (King’s College London, United Kingdom): Impaired gut resolution pathways enable virulent behaviour of Porphyromonas gingivalis in inflammatory arthritis |
| 7 | 14th January | Valerie Urbach (French Institute of Health and Medical Research— INSERM, France): Specialized Pro-Resolving Mediators in Cystic Fibrosis Airway Disease |
| 8 | 21st January | Minna Holopainen (University of Helsinki, Finland): Lipid, fatty acid and lipid mediator analysis towards one health |
| 9 | 28th January | Jesmond Dalli (Queen Mary University of London, United Kingdom): Erythroblast-derived signals imprint neutrophil development |
| 10 | 4th February | Cristina López-Vicario (Hospital Clinic de Barcelona, Spain): Lipid Mediators and Mitochondrial Dysfunction in Chronic Liver Disease |
| 11 | 11th February | Vaishnavi Sirul Velaga (University of Rostock, Germany): A Knowledge Graph and RAG-Based Chatbot for Specialized Pro-Resolving Lipid Mediators (SPMs) |
| 12 | 18th February | Alexandra Gouveia (Faculty of Medicine, University of Porto, Portugal): The Role of Melanocortins on Adipose Tissue Remodelling |
| 13 | 25th February | WG1 Subgroup A (WG1sgA) session led by Helen Griffiths (Swansea University, United Kingdom): Use of Delphi questionnaires for defining Resolution Biology and underlying mechanisms |
| 14 | 4th March | David W. Lescheid (Medical Manager Heel GmBH, Germany): Testing the Mode-of-Action of Pro-Resolution Drugs in a Human Clinical Setting |
| 15 | 11th March | Luke Baker (University of Leicester, United Kingdom): Resolution physiology in the context of sarcopenia |
| 16 | 18th March | Valerio Chiurchiù (Institute of Translational Pharmacology, CNR & IRCCS Santa Lucia Foundation, Italy): RvD1 reshapes immune cell dynamics and reprograms neuroglia interactions in Parkinson’s disease |
| 17 | 25th March | Suman Muralidharan (University of Rostock, Germany): Strategies and Challenges in Linking Imaging Parameters with Molecular Interaction Maps |
| 18 | 1st April | Emmanuel Albuquerque-Souza (Queen Mary University of London, United Kingdom): A macrophage lipid mediator circuit programs distal gut immunity and sex-biased colitis |
| 19 | 8th April | Mario Romano (Università Degli Studi Gabriele D’Annunzio Di Chieti-Pescara, Italy): Cystic Fibrosis and Resolution of Inflammation |
| 20 | 15th April | Semira Galijasevic (Sarajevo School of Science and Technology, Bosnia and Herzegovina): Myeloperoxidase, oxidative stress, and inflammation – can we stop it? |
| 21 | 22nd April | Raquel Guillamat Prats (Germans Trias i Pujol Health Science Research Institute, Spain): Role of GPR55/LPI axis in neutrophil activation in respiratory infections |
| 22 | 29th April | Martin Schlegel (TUM University Hospital, Germany): From inflammation to resolution: Challenges in profiling lipid mediators in critical illness |
| 23 | 6th May | Kristiaan Wouters (Maastricht University, the Netherlands): Immunometabolism and the modulation of immune responses – A role for methylglyoxal |
| 24 | 13th May | Tal Burstyn-Cohen (The Hebrew University of Jerusalem, Israel): Joint iiSIAR—EU-RESOLVE webinar: PROS1-TAM Signalling in Microglia Regulates Microglia Development, Homeostasis and Sterile Inflammation |
| 25 | 20th May | Olga Pechanova (Centre of Experimental Medicine, Slovak Academy of Sciences, Slovakia): Hormetic Effects of Polyphenol-Rich Cornus mas on Redox Balance: Evidence from Animal and Human Studies |
| 26 | 27th May | Tommaso Lomonaco (Università di Pisa, Italy): Alternative strategies to monitor Heart Failure disease |
| 27 | 3rd June | Ikbal Agah INCE (Acibadem University, Turkey): Targeted Methylation Analysis of human mitochondria |
| 28 | 10th June | Miron Sopić (University of Belgrade, Serbia): AtherOMICS Research Group: Multiomics Approaches to Study Inflammation After Myocardial Infarction |
| 29 | 9th September | Robert Hoffstetter (Friedrich Schiller University Jena, Germany): Towards Reproducible Oxylipin Quantification: Harmonising LC-MS/MS Data Processing Across Laboratories |
| 30 | 16th September | Rosanna Chung (Linköping University, Sweden): Immune dysfunction in atherosclerosis. Can optimizing carotenoid bioavailability be the answer? |
| 31 | 23rd September | Joan Clària (University of Barcelona and Hospital Clinic of Barcelona, Spain): Immune dysfunction and impaired resolution capacity in advanced liver disease |
